Cargando…
Identifying and Prioritizing Gaps in Neuroendocrine Tumor Research: A Modified Delphi Process With Patients and Health Care Providers to Set the Research Action Plan for the Newly Formed Commonwealth Neuroendocrine Tumor Collaboration
PURPOSE: Neuroendocrine tumors (NETs) are a diverse group of malignancies that pose challenges common to all rare tumors. The Commonwealth Neuroendocrine Tumor Collaboration (CommNETS) was established in 2015 to enhance outcomes for patients with NETs in Canada, Australia, and New Zealand. A modifie...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society of Clinical Oncology
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5560462/ https://www.ncbi.nlm.nih.gov/pubmed/28831446 http://dx.doi.org/10.1200/JGO.2016.006916 |
_version_ | 1783257665687781376 |
---|---|
author | Segelov, Eva Chan, David Lawrence, Ben Pavlakis, Nick Kennecke, Hagen F. Jackson, Christopher Law, Calvin Singh, Simron |
author_facet | Segelov, Eva Chan, David Lawrence, Ben Pavlakis, Nick Kennecke, Hagen F. Jackson, Christopher Law, Calvin Singh, Simron |
author_sort | Segelov, Eva |
collection | PubMed |
description | PURPOSE: Neuroendocrine tumors (NETs) are a diverse group of malignancies that pose challenges common to all rare tumors. The Commonwealth Neuroendocrine Tumor Collaboration (CommNETS) was established in 2015 to enhance outcomes for patients with NETs in Canada, Australia, and New Zealand. A modified Delphi process was undertaken involving patients, clinicians, and researchers to identify gaps in NETs research to produce a comprehensive and defensible research action plan. METHODS: A three-round modified Delphi process was undertaken with larger representation than usual for medical consensus processes. Patient/advocate and health care provider/researcher expert panels undertook Round 1, which canvassed 17 research priorities and 42 potential topics; in Round 2, these priorities were ranked. Round 3 comprised a face-to-face meeting to generate final consensus rankings and formulate the research action plan. RESULTS: The Delphi groups consisted of 203 participants in Round 1 (64% health care providers/researchers, 36% patient/advocates; 52% Canadian, 32% Australian, and 17% New Zealander), of whom 132 participated in Round 2. The top eight priorities were biomarker development; peptide receptor radionuclide therapy optimization; trials of new agents in advanced NETs; functional imaging; sequencing therapies for metastatic NETs, including development of validated surrogate end points for studies; pathologic classification; early diagnosis; interventional therapeutics; and curative surgery. Two major areas were ranked significantly higher by patients/advocates: early diagnosis and curative surgery. Six CommNETS working parties were established. CONCLUSION: This modified Delphi process resulted in a well-founded set of research priorities for the newly formed CommNETS collaboration by involving a large, diverse group of stakeholders. This approach to setting a research agenda for a new collaborative group should be adopted to ensure that research plans reflect unmet needs and priorities in the field. |
format | Online Article Text |
id | pubmed-5560462 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2016 |
publisher | American Society of Clinical Oncology |
record_format | MEDLINE/PubMed |
spelling | pubmed-55604622017-08-22 Identifying and Prioritizing Gaps in Neuroendocrine Tumor Research: A Modified Delphi Process With Patients and Health Care Providers to Set the Research Action Plan for the Newly Formed Commonwealth Neuroendocrine Tumor Collaboration Segelov, Eva Chan, David Lawrence, Ben Pavlakis, Nick Kennecke, Hagen F. Jackson, Christopher Law, Calvin Singh, Simron J Glob Oncol ORIGINAL REPORTS PURPOSE: Neuroendocrine tumors (NETs) are a diverse group of malignancies that pose challenges common to all rare tumors. The Commonwealth Neuroendocrine Tumor Collaboration (CommNETS) was established in 2015 to enhance outcomes for patients with NETs in Canada, Australia, and New Zealand. A modified Delphi process was undertaken involving patients, clinicians, and researchers to identify gaps in NETs research to produce a comprehensive and defensible research action plan. METHODS: A three-round modified Delphi process was undertaken with larger representation than usual for medical consensus processes. Patient/advocate and health care provider/researcher expert panels undertook Round 1, which canvassed 17 research priorities and 42 potential topics; in Round 2, these priorities were ranked. Round 3 comprised a face-to-face meeting to generate final consensus rankings and formulate the research action plan. RESULTS: The Delphi groups consisted of 203 participants in Round 1 (64% health care providers/researchers, 36% patient/advocates; 52% Canadian, 32% Australian, and 17% New Zealander), of whom 132 participated in Round 2. The top eight priorities were biomarker development; peptide receptor radionuclide therapy optimization; trials of new agents in advanced NETs; functional imaging; sequencing therapies for metastatic NETs, including development of validated surrogate end points for studies; pathologic classification; early diagnosis; interventional therapeutics; and curative surgery. Two major areas were ranked significantly higher by patients/advocates: early diagnosis and curative surgery. Six CommNETS working parties were established. CONCLUSION: This modified Delphi process resulted in a well-founded set of research priorities for the newly formed CommNETS collaboration by involving a large, diverse group of stakeholders. This approach to setting a research agenda for a new collaborative group should be adopted to ensure that research plans reflect unmet needs and priorities in the field. American Society of Clinical Oncology 2016-10-12 /pmc/articles/PMC5560462/ /pubmed/28831446 http://dx.doi.org/10.1200/JGO.2016.006916 Text en © 2016 by American Society of Clinical Oncology http://creativecommons.org/licenses/by-nc-nd/4.0/ Licensed under the Creative Commons Attribution 4.0 License: http://creativecommons.org/licenses/by-nc-nd/4.0/. |
spellingShingle | ORIGINAL REPORTS Segelov, Eva Chan, David Lawrence, Ben Pavlakis, Nick Kennecke, Hagen F. Jackson, Christopher Law, Calvin Singh, Simron Identifying and Prioritizing Gaps in Neuroendocrine Tumor Research: A Modified Delphi Process With Patients and Health Care Providers to Set the Research Action Plan for the Newly Formed Commonwealth Neuroendocrine Tumor Collaboration |
title | Identifying and Prioritizing Gaps in Neuroendocrine Tumor Research: A Modified Delphi Process With Patients and Health Care Providers to Set the Research Action Plan for the Newly Formed Commonwealth Neuroendocrine Tumor Collaboration |
title_full | Identifying and Prioritizing Gaps in Neuroendocrine Tumor Research: A Modified Delphi Process With Patients and Health Care Providers to Set the Research Action Plan for the Newly Formed Commonwealth Neuroendocrine Tumor Collaboration |
title_fullStr | Identifying and Prioritizing Gaps in Neuroendocrine Tumor Research: A Modified Delphi Process With Patients and Health Care Providers to Set the Research Action Plan for the Newly Formed Commonwealth Neuroendocrine Tumor Collaboration |
title_full_unstemmed | Identifying and Prioritizing Gaps in Neuroendocrine Tumor Research: A Modified Delphi Process With Patients and Health Care Providers to Set the Research Action Plan for the Newly Formed Commonwealth Neuroendocrine Tumor Collaboration |
title_short | Identifying and Prioritizing Gaps in Neuroendocrine Tumor Research: A Modified Delphi Process With Patients and Health Care Providers to Set the Research Action Plan for the Newly Formed Commonwealth Neuroendocrine Tumor Collaboration |
title_sort | identifying and prioritizing gaps in neuroendocrine tumor research: a modified delphi process with patients and health care providers to set the research action plan for the newly formed commonwealth neuroendocrine tumor collaboration |
topic | ORIGINAL REPORTS |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5560462/ https://www.ncbi.nlm.nih.gov/pubmed/28831446 http://dx.doi.org/10.1200/JGO.2016.006916 |
work_keys_str_mv | AT segeloveva identifyingandprioritizinggapsinneuroendocrinetumorresearchamodifieddelphiprocesswithpatientsandhealthcareproviderstosettheresearchactionplanforthenewlyformedcommonwealthneuroendocrinetumorcollaboration AT chandavid identifyingandprioritizinggapsinneuroendocrinetumorresearchamodifieddelphiprocesswithpatientsandhealthcareproviderstosettheresearchactionplanforthenewlyformedcommonwealthneuroendocrinetumorcollaboration AT lawrenceben identifyingandprioritizinggapsinneuroendocrinetumorresearchamodifieddelphiprocesswithpatientsandhealthcareproviderstosettheresearchactionplanforthenewlyformedcommonwealthneuroendocrinetumorcollaboration AT pavlakisnick identifyingandprioritizinggapsinneuroendocrinetumorresearchamodifieddelphiprocesswithpatientsandhealthcareproviderstosettheresearchactionplanforthenewlyformedcommonwealthneuroendocrinetumorcollaboration AT kenneckehagenf identifyingandprioritizinggapsinneuroendocrinetumorresearchamodifieddelphiprocesswithpatientsandhealthcareproviderstosettheresearchactionplanforthenewlyformedcommonwealthneuroendocrinetumorcollaboration AT jacksonchristopher identifyingandprioritizinggapsinneuroendocrinetumorresearchamodifieddelphiprocesswithpatientsandhealthcareproviderstosettheresearchactionplanforthenewlyformedcommonwealthneuroendocrinetumorcollaboration AT lawcalvin identifyingandprioritizinggapsinneuroendocrinetumorresearchamodifieddelphiprocesswithpatientsandhealthcareproviderstosettheresearchactionplanforthenewlyformedcommonwealthneuroendocrinetumorcollaboration AT singhsimron identifyingandprioritizinggapsinneuroendocrinetumorresearchamodifieddelphiprocesswithpatientsandhealthcareproviderstosettheresearchactionplanforthenewlyformedcommonwealthneuroendocrinetumorcollaboration |